Profile data is unavailable for this security.
About the company
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
- Revenue in CHF (TTM)3.78bn
- Net income in CHF-12.43m
- Incorporated2022
- Employees6.55k
- LocationGalderma Group AGZaehlerweg 10ZUG 6300SwitzerlandCHE
- Websitehttps://www.galderma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Group AG | 3.78bn | -12.43m | 19.90bn | 6.55k | -- | 2.97 | 83.19 | 5.27 | -0.0524 | -0.0524 | 15.91 | 28.12 | -- | -- | -- | 577,403.80 | -- | -- | -- | -- | 69.54 | -- | -0.3266 | -- | 0.9206 | 1.20 | 0.2786 | -- | 7.65 | -- | 40.97 | -- | -- | -- |
| Beiersdorf AG | 9.09bn | 692.62m | 29.06bn | 22.49k | 38.33 | 3.33 | 29.21 | 3.20 | 3.26 | 3.26 | 42.71 | 37.47 | 0.738 | 2.69 | 4.45 | 441,114.80 | 5.71 | 6.38 | 8.28 | 8.95 | 58.14 | 57.23 | 7.74 | 8.60 | 1.34 | -- | 0.0622 | 25.33 | 7.36 | 5.49 | -2.52 | 0.2188 | 7.63 | 7.39 |
| Reckitt Benckiser Group Plc | 16.21bn | 1.75bn | 37.21bn | 40.00k | 21.97 | 4.13 | 16.26 | 2.29 | 2.17 | 2.17 | 20.07 | 11.54 | 0.5314 | 3.49 | 6.58 | 358,200.00 | 5.75 | 1.54 | 8.25 | 2.10 | 60.56 | 59.32 | 10.81 | 3.37 | 0.4692 | 18.66 | 0.5237 | 283.98 | 1.07 | 3.01 | -30.08 | -5.48 | 0.5433 | 2.43 |
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 4.38m | 1.84% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 3.75m | 1.58% |
| Pictet Asset Management SAas of 30 Jun 2024 | 3.58m | 1.50% |
| UBS Asset Management Switzerland AGas of 30 Sep 2024 | 2.46m | 1.04% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.98m | 0.83% |
| J.O. Hambro Capital Management Ltd.as of 30 Sep 2024 | 1.33m | 0.56% |
| Z�rcher Kantonalbank (Investment Management)as of 30 Aug 2024 | 1.30m | 0.55% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 807.19k | 0.34% |
| Union Investment Privatfonds GmbHas of 31 Mar 2024 | 651.40k | 0.27% |
| Polar Capital LLPas of 30 Sep 2024 | 644.33k | 0.27% |
